BRIEF-Vivus up in premarket after qsymia study results
NEW YORK Feb 1 (Reuters) - Vivus Inc : * Up 4.1 percent to $12.60 in premarket after qsymia study results
- Exclusive: Angry with Washington, 1 in 4 Americans open to secession
- U.S. Secret Service investigates after man jumps White House fence, reaches doors
- French jets strike in Iraq, expanding U.S.-led campaign against Islamic State |
- North Korea says imprisoned American tried to become 'second Snowden'
- Alice, steampunk and a false name: enigma of an American jailed in North Korea